Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Новые технологии в управлении сахарным диабетом: от теории – к практике
Барсуков И.А., Демина А.А. Новые технологии в управлении сахарным диабетом: от теории – к практике. Consilium Medicum. 2018; 20 (4): 24–28. DOI: 10.26442/2075-1753_2018.4.24-28
________________________________________________
Barsukov I.A., Demina A.A. New technologies in diabetes mellitus management: from theory to practice. Consilium Medicum. 2018; 20 (4): 24–28. DOI: 10.26442/2075-1753_2018.4.24-28
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
На сегодняшний день сахарный диабет является одной из наиболее приоритетных медико-социальных проблем. Стремительно возросшая в течение последних 20 лет заболеваемость сахарным диабетом требует активной разработки не только новых способов лечения, но и диагностики данного заболевания. Арсенал врачей-эндокринологов постоянно пополняется методами контроля уровня гликемии: новыми, улучшенными глюкометрами, а также системами непрерывного мониторирования гликемии. Учитывая, что от точности измерения зависит подбор терапии и, следовательно, уровень компенсации углеводного обмена, крайне важно, чтобы используемый пациентом глюкометр соответствовал всем необходимым стандартам. Наиболее перспективным методом лечения является инсулинотерапия посредством инсулиновой помпы, эффективность которой неоднократно была подтверждена в клинических исследованиях.
Ключевые слова: глюкометр, инсулиновая помпа, самоконтроль гликемии, непрерывное мониторирование гликемии.________________________________________________
At present time diabetes mellitus is one of the top-priority medical and social problems. The increased over the past 20 years diabetes mellitus incidence requires development not only of new treatment strategies but also of diagnostic methods. The number of endocrinologists' methods of glucose control constantly increases with new ones: new upgraded glucometers and continuous glucose monitoring systems. Considering that the measurement accuracy defines therapy choice and, therefore, degree of compensation of carbohydrate metabolism, it is quite important that patients' glucometers match the required standards. Insulin therapy with insulin pump is one of the most perspective treatment methods, its effectiveness has been repeatedly confirmed in clinical trials.
Key words: glucometer, insulin pump, self-monitoring of blood glucose, continuous glucose monitoring.Полный текст
Список литературы
1. Глобальный доклад по диабету. ВОЗ, 2016. / Global'nyi doklad po diabetu. VOZ, 2016. [in Russian]
2. Tietz Fundamentals of Clinical Chemistry, 4th Edition. Editors Burtis and Ashwood. W.B. Saunders Company, 1996; p. 43–52.3. Diabetes Association. Diabetes and classification of diabetes mellitus. Diabetes care 2004; 27 (Suppl. 1): S5–S10.
4. Тест-системы для диагностики in vitro. Требования к системам мониторинга глюкозы в крови для самоконтроля при лечении сахарного диабета [Электронный ресурс]: ГОСТ Р ИСО 15197-2015. Введ. 2016-06-01. http://docs.cntd.ru/document/1200120137. (Дата обращения 17.10.2017) / Test-sistemy dlia diagnostiki in vitro. Trebovaniia k sistemam monitoringa gliukozy v krovi dlia samokontrolia pri lechenii sakharnogo diabeta [Elektronnyi resurs]: GOST R ISO 15197-2015. Vved. 2016-06-01. http://docs.cntd.ru/document/1200120137. (Data obrashcheniia 17.10.2017) [in Russian]
5. Wahl PW, Savage PJ, Psaty BM et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 1998; 352: 1012–15.
6. Древаль А.В., Мисникова И.В., Барсуков И.А. и др. Распространенность сахарного диабета 2 типа и ранних нарушений углеводного обмена среди взрослого населения Московской области. Ожирение и метаболизм. 2008; 2 (15): 11–6. / Dreval A.V., Misnikova I.V., Barsukov I.A. i dr. Rasprostranennost' sakharnogo diabeta 2 tipa i rannikh narushenii uglevodnogo obmena sredi vzroslogo naseleniia Moskovskoi oblasti. Ozhirenie i metabolizm. 2008; 2 (15): 11–6. [in Russian]
7. Сахарный диабет 1 типа: реалии и перспективы. Под ред. И.И.Дедова, М.В.Шестаковой. М.: Мед. информ. агентство, 2016; с. 380–93. / Sakharnyi diabet 1 tipa: realii i perspektivy. Pod red. I.I.Dedova, M.V.Shestakovoi. M.: Med. inform. agentstvo, 2016; s. 380–93. [in Russian]
8. Pickup JC, Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 2002; 25: 593–8.
9. Bode BW, Sabbah HT, Gross TM et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002; 18 (Suppl. 1): S14–20.
10. Pickup J, Mattock M, Kerry S. Glycemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes. BMJ 2002; 324: 705–8.
11. Hoogma RP, Hammond PJ, Gomis R et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life. Diabet Med 2006; 23: 141–7.
12. Rodriguеs AS, Reid HA, Ismail K et al. Indications and efficacy of continuоus subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med 2005; 22 (7): 842–9.
13. American Diabetes Association. Standards of medical care in diabetes – 2017. Diabetes Care 2017; 40 (Suppl. 1): S1–S2.
14. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю. Майорова. Вып. 8. М.: УП Принт, 2017. / Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Yu. Maiorova. Vyp. 8. M.: UP Print, 2017. [in Russian]
15. Древаль А.В., Барсуков И.А., Шестакова Т.П. и др. Помповая инсулинотерапия и непрерывное мониторирование гликемии: опыт клинической практики в рамках оказания высокотехнологичной медицинской помощи. РМЖ. 2017; 1: 3–8. / Dreval A.V., Barsukov I.A., Shestakova T.P. i dr. Pompovaia insulinoterapiia i nepreryvnoe monitorirovanie glikemii: opyt klinicheskoi praktiki v ramkakh okazaniia vysokotekhnologichnoi meditsinskoi pomoshchi. RMZh. 2017; 1: 3–8. [in Russian]
16. Walsh J et al. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol 2010; 4: 1174–81.
17. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231–9.
18. Древаль О.А. Непрерывное мониторирование гликемии в оценке эффективности лечения сахарного диабета. Автореф. дис. ... канд. мед. наук. М., 2013. / Dreval O.A. Nepreryvnoe monitorirovanie glikemii v otsenke effektivnosti lecheniia sakharnogo diabeta. Avtoref. dis. ... kand. med. nauk. M., 2013. [in Russian]
19. Dunne N., Viggiani M.T. Accuracy Evaluation of CONTOUR_PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6: 377–88.
20. Baum JM et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. Diab Tech Ther 2006; 8 (3): 347–57.
21. Koschinsky T et al. Glucose monitoring at the arm – Risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002; 25: 956–60.
22. Engelgau MM, Narayan V, Herman W. Screening for type 2 diabetes. Diabetes care 2000; 23 (10): 1563–80.
23 Lawrence J, Robinson A. Screening for diabetes in general practice. Prev Cardiol 2003; 6 (2): 78–84.
________________________________________________
1. Global'nyi doklad po diabetu. VOZ, 2016. [in Russian]
2. Tietz Fundamentals of Clinical Chemistry, 4th Edition. Editors Burtis and Ashwood. W.B. Saunders Company, 1996; p. 43–52.
3. Diabetes Association. Diabetes and classification of diabetes mellitus. Diabetes care 2004; 27 (Suppl. 1): S5–S10.
4. Test-sistemy dlia diagnostiki in vitro. Trebovaniia k sistemam monitoringa gliukozy v krovi dlia samokontrolia pri lechenii sakharnogo diabeta [Elektronnyi resurs]: GOST R ISO 15197-2015. Vved. 2016-06-01. http://docs.cntd.ru/document/1200120137. (Data obrashcheniia 17.10.2017) [in Russian]
5. Wahl PW, Savage PJ, Psaty BM et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 1998; 352: 1012–15.
6. Dreval A.V., Misnikova I.V., Barsukov I.A. i dr. Rasprostranennost' sakharnogo diabeta 2 tipa i rannikh narushenii uglevodnogo obmena sredi vzroslogo naseleniia Moskovskoi oblasti. Ozhirenie i metabolizm. 2008; 2 (15): 11–6. [in Russian]
7. Sakharnyi diabet 1 tipa: realii i perspektivy. Pod red. I.I.Dedova, M.V.Shestakovoi. M.: Med. inform. agentstvo, 2016; s. 380–93. [in Russian]
8. Pickup JC, Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 2002; 25: 593–8.
9. Bode BW, Sabbah HT, Gross TM et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002; 18 (Suppl. 1): S14–20.
10. Pickup J, Mattock M, Kerry S. Glycemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes. BMJ 2002; 324: 705–8.
11. Hoogma RP, Hammond PJ, Gomis R et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life. Diabet Med 2006; 23: 141–7.
12. Rodriguеs AS, Reid HA, Ismail K et al. Indications and efficacy of continuоus subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med 2005; 22 (7): 842–9.
13. American Diabetes Association. Standards of medical care in diabetes – 2017. Diabetes Care 2017; 40 (Suppl. 1): S1–S2.
14. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Yu. Maiorova. Vyp. 8. M.: UP Print, 2017. [in Russian]
15. Dreval A.V., Barsukov I.A., Shestakova T.P. i dr. Pompovaia insulinoterapiia i nepreryvnoe monitorirovanie glikemii: opyt klinicheskoi praktiki v ramkakh okazaniia vysokotekhnologichnoi meditsinskoi pomoshchi. RMZh. 2017; 1: 3–8. [in Russian]
16. Walsh J et al. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol 2010; 4: 1174–81.
17. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231–9.
18. Dreval O.A. Nepreryvnoe monitorirovanie glikemii v otsenke effektivnosti lecheniia sakharnogo diabeta. Avtoref. dis. ... kand. med. nauk. M., 2013. [in Russian]
19. Dunne N., Viggiani M.T. Accuracy Evaluation of CONTOUR_PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6: 377–88.
20. Baum JM et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. Diab Tech Ther 2006; 8 (3): 347–57.
21. Koschinsky T et al. Glucose monitoring at the arm – Risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002; 25: 956–60.
22. Engelgau MM, Narayan V, Herman W. Screening for type 2 diabetes. Diabetes care 2000; 23 (10): 1563–80.
23 Lawrence J, Robinson A. Screening for diabetes in general practice. Prev Cardiol 2003; 6 (2): 78–84.
2. Tietz Fundamentals of Clinical Chemistry, 4th Edition. Editors Burtis and Ashwood. W.B. Saunders Company, 1996; p. 43–52.
3. Diabetes Association. Diabetes and classification of diabetes mellitus. Diabetes care 2004; 27 (Suppl. 1): S5–S10.
4. Test-sistemy dlia diagnostiki in vitro. Trebovaniia k sistemam monitoringa gliukozy v krovi dlia samokontrolia pri lechenii sakharnogo diabeta [Elektronnyi resurs]: GOST R ISO 15197-2015. Vved. 2016-06-01. http://docs.cntd.ru/document/1200120137. (Data obrashcheniia 17.10.2017) [in Russian]
5. Wahl PW, Savage PJ, Psaty BM et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 1998; 352: 1012–15.
6. Dreval A.V., Misnikova I.V., Barsukov I.A. i dr. Rasprostranennost' sakharnogo diabeta 2 tipa i rannikh narushenii uglevodnogo obmena sredi vzroslogo naseleniia Moskovskoi oblasti. Ozhirenie i metabolizm. 2008; 2 (15): 11–6. [in Russian]
7. Sakharnyi diabet 1 tipa: realii i perspektivy. Pod red. I.I.Dedova, M.V.Shestakovoi. M.: Med. inform. agentstvo, 2016; s. 380–93. [in Russian]
8. Pickup JC, Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 2002; 25: 593–8.
9. Bode BW, Sabbah HT, Gross TM et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002; 18 (Suppl. 1): S14–20.
10. Pickup J, Mattock M, Kerry S. Glycemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes. BMJ 2002; 324: 705–8.
11. Hoogma RP, Hammond PJ, Gomis R et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life. Diabet Med 2006; 23: 141–7.
12. Rodriguеs AS, Reid HA, Ismail K et al. Indications and efficacy of continuоus subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med 2005; 22 (7): 842–9.
13. American Diabetes Association. Standards of medical care in diabetes – 2017. Diabetes Care 2017; 40 (Suppl. 1): S1–S2.
14. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi, A.Yu. Maiorova. Vyp. 8. M.: UP Print, 2017. [in Russian]
15. Dreval A.V., Barsukov I.A., Shestakova T.P. i dr. Pompovaia insulinoterapiia i nepreryvnoe monitorirovanie glikemii: opyt klinicheskoi praktiki v ramkakh okazaniia vysokotekhnologichnoi meditsinskoi pomoshchi. RMZh. 2017; 1: 3–8. [in Russian]
16. Walsh J et al. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol 2010; 4: 1174–81.
17. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231–9.
18. Dreval O.A. Nepreryvnoe monitorirovanie glikemii v otsenke effektivnosti lecheniia sakharnogo diabeta. Avtoref. dis. ... kand. med. nauk. M., 2013. [in Russian]
19. Dunne N., Viggiani M.T. Accuracy Evaluation of CONTOUR_PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6: 377–88.
20. Baum JM et al. Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors. Diab Tech Ther 2006; 8 (3): 347–57.
21. Koschinsky T et al. Glucose monitoring at the arm – Risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002; 25: 956–60.
22. Engelgau MM, Narayan V, Herman W. Screening for type 2 diabetes. Diabetes care 2000; 23 (10): 1563–80.
23 Lawrence J, Robinson A. Screening for diabetes in general practice. Prev Cardiol 2003; 6 (2): 78–84.
Авторы
И.А.Барсуков*, А.А.Демина
ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф.Владимирского». 129110, Россия, Москва, ул. Щепкина, д. 61/2
________________________________________________
I.A.Barsukov*, A.A.Demina
M.F.Vladimirskiy Moscow Regional Clinical Institute. 129110, Russian Federation, Moscow, ul. Shchepkina, d. 61/2
*palantirr@inbox.ru
*palantirr@inbox.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.